<DOC>
	<DOCNO>NCT01103440</DOCNO>
	<brief_summary>The objective study evaluate aggressive antiplatelet therapy would reduce ischemic event aspirin ( ASA ) resistant patient percutaneous coronary intervention ( PCI ) .</brief_summary>
	<brief_title>Aspirin Resistance Percutaneous Coronary Intervention ( PCI )</brief_title>
	<detailed_description>This first US base randomize double blind prospective study use triple antiplatelet therapy double dose plavix maintenance dose aspirin resistant patient undergo elective PCI femoral access . The primary outcome study elevation cardiac enzyme within 24 hour PCI secondary outcome composite major adverse cardiac event death , MI , stent thrombosis urgent revascularization bleed 30 day .</detailed_description>
	<mesh_term>Angina , Stable</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Krestin</mesh_term>
	<criteria>Age old 18 year Scheduled elective adhos PCI Aspirin use daily great equal one week Aspirin resistant ( ARU great equal 550 Verify NowASA Preprocedural elevation cardiac biomarkers ( CKMB great equal 10.4ng/dl Tnl great equal 0.4ng/dl administration GP IIb/IIIa inhibitor , anticoagulation lytic therapy previous 30 day Ongoing bleed bleed diathesis , contraindication anticoagulation increase bleeding risk history bleed last eight week Previous stroke transient ischemic attack intracranial pathology last six month , major surgery trauma within previous six week Platelet count less hundred thousand per cubic millimeter hematocrit &lt; 33 % hemoglobin &lt; 11 g per deciliter Subjects receive full dose low molecular weight heparin within six hour prior randomization Allergy intolerance study drug presence serious comorbidity life expectancy â‰¤1year Scheduled saphenous vein graft intervention , chronic total occlusion impair renal function ( eGFR &lt; 60ml/min ) patient take anticoagulant antiplatelet agent aspirin clopidogrel nonsteroidal antiinflammatory drug within two week PCI procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Major Adverse Cardiovascular Event</keyword>
	<keyword>MACE</keyword>
	<keyword>Death</keyword>
	<keyword>MI</keyword>
	<keyword>CK MB great 3x Normal</keyword>
	<keyword>Urgent Revascularization</keyword>
	<keyword>Stent Thrombosis</keyword>
	<keyword>Bleeding</keyword>
</DOC>